Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients

Grant

Total Award Amount

  • 14800.00
  • Direct Costs

  • 11746.00
  • Sponsor Award Id